Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Anal Chem ; 85(4): 2348-55, 2013 Feb 19.
Article in English | MEDLINE | ID: mdl-23301726

ABSTRACT

Cluster bombardments of 15 keV C(60) on metal-organic interfaces composed of silver atoms and octatetraene molecules were modeled using molecular dynamics computer simulations. Dynamics revealed by the simulations include the formation of holes in the metal overlayers from which underlying organic molecules are sputtered predominantly by a rapid jetlike motion and the implantation of metal atoms and clusters in the underlying organic solid. Both of these processes negatively affect the information depth for cluster bombardment of metal-organic interfaces; therefore, the simulations presented here give a clear picture of the issues associated with depth profiling through metal-organic interfaces.

3.
J Magn Reson ; 196(2): 191-9, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19083249

ABSTRACT

Competition between nutation (r.f. driven) and adiabatic (rotor-driven) multi-quantum coherence transfer mechanisms in spin 3/2 systems results in diminished performance of rotation induced adiabatic coherence transfer (RIACT) in isotropic multiple-quantum magic-angle spinning (MQMAS) experiments for small e(2)qQ/h (<2 MHz) and high radio-frequency powers. We present a simple shaped RIACT pulse consisting of a truncated sine wave (spanning 0-0.8pi) that corrects the sensitivity losses, phase twist and relative intensity errors that can arise in MQMAS spectra utilizing constant-amplitude RIACT pulses. The shaped RIACT pulse may enhance the study of metals in biomolecules where quadrupole couplings of S=3/2 nuclei such as (23)Na tend to be small.


Subject(s)
Magnetic Resonance Spectroscopy/methods , Sodium/chemistry , Spin Labels , Electromagnetic Fields , Magnetics , Quantum Theory , Spectrum Analysis , Tomography, Optical Coherence
4.
J Leukoc Biol ; 80(5): 1175-82, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16923920

ABSTRACT

Highly active antiretroviral therapy (HAART) against human immunodeficiency virus type 1 (HIV-1) infection dramatically suppresses viral load, leading to marked reductions in HIV-1 associated morbidity and mortality. However, infected cell reservoirs and low-level replication persist in the face of suppressive HAART, leading invariably to viral rebound upon cessation of treatment. Toxins engineered to target the Env glycoprotein on the surface of productively infected cells represent a complementary strategy to deplete these reservoirs. We described previously highly selective killing of Env-expressing cell lines by CD4(178)-PE40 and 3B3(Fv)-PE38, recombinant derivatives of Pseudomonas aeruginosa exotoxin A containing distinct targeting moieties against gp120. In the present report, we compare the in vitro potency and breadth of these chimeric toxins against multiple clinical HIV-1 isolates, replicating in biologically relevant primary human target cell types. In PBMCs, 3B3(Fv)-PE38 blocked spreading infection by all isolates examined, with greater potency than CD4(178)-PE40. 3B3(Fv)-PE38 also potently inhibited spreading HIV-1 infection in primary macrophages. Control experiments demonstrated that in both target cell types, most of the 3B3(Fv)-PE38 activity was due to selective killing of infected cells, and not merely to neutralization by the antibody moiety of the chimeric toxin. High-dose treatment of rhesus macaques with 3B3(Fv)-PE38 did not induce liver toxicity, whereas equivalent dosage of CD4(178)-PE40 induced mild hepatotoxicity. These findings highlight the potential use of 3B3(Fv)-PE38 for depleting HIV-infected cell reservoirs persisting in the face of HAART.


Subject(s)
Anti-HIV Agents/pharmacology , HIV/drug effects , Immunotoxins/pharmacology , Leukocytes, Mononuclear/drug effects , Macrophages/drug effects , Animals , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/adverse effects , Chemical and Drug Induced Liver Injury , Dose-Response Relationship, Drug , Exotoxins/administration & dosage , Exotoxins/adverse effects , Exotoxins/pharmacology , HIV/isolation & purification , Humans , Immunotoxins/administration & dosage , Immunotoxins/adverse effects , Injections, Intravenous , Leukocytes, Mononuclear/virology , Liver Diseases/pathology , Macaca , Macrophages/virology , Models, Animal , Recombinant Proteins/administration & dosage , Recombinant Proteins/adverse effects , Recombinant Proteins/pharmacology , Structure-Activity Relationship , Virus Replication/drug effects
5.
J Biol Chem ; 277(37): 34383-90, 2002 Sep 13.
Article in English | MEDLINE | ID: mdl-12119300

ABSTRACT

HIV-infected cells are selectively killed by an immunotoxin in which a truncated form of Pseudomonas exotoxin A is joined to the variable region of a broadly neutralizing antibody (3B3) that recognizes the viral envelope glycoprotein (Env). To improve the efficacy of this molecule, we used three-dimensional structural information and phage selection data to design 23 single and multiple point mutations in the antibody variable region sequences that contact Env. Substituting an aromatic residue for an aspartate in the third complementarity-determining region of V(H) increased the potency of the immunotoxin by approximately 10-fold in a cell-killing assay. Detailed analysis of one such mutant, N31H/Q100eY, revealed both a higher affinity for monomeric and cell surface Env and an increased stability against aggregation compared with the starting immunotoxin. Conversion to a disulfide-linked two-chain format further stabilized the protein. N31H/Q100eY retained the ability to bind to Env from multiple viral isolates, to inhibit Env-mediated cell fusion, and to limit spreading viral infection in peripheral blood mononuclear cells. Such site-directed mutants may increase the utility of immunotoxins for reducing or eradicating persistent HIV-1 infection in humans.


Subject(s)
ADP Ribose Transferases/chemistry , Anti-HIV Agents/chemistry , Bacterial Toxins/chemistry , Exotoxins/chemistry , HIV-1/drug effects , Immunotoxins/chemistry , Viral Envelope Proteins/chemistry , Virulence Factors/chemistry , ADP Ribose Transferases/metabolism , Bacterial Toxins/metabolism , Drug Stability , Exotoxins/metabolism , HIV Envelope Protein gp120/metabolism , Humans , Immunotoxins/metabolism , Membrane Fusion , Mutagenesis , Structure-Activity Relationship , Viral Envelope Proteins/metabolism , Virulence Factors/metabolism , Pseudomonas aeruginosa Exotoxin A
SELECTION OF CITATIONS
SEARCH DETAIL